ZNF319 may be involved in transcriptional regulation.
Applications:
Suitable for use in Western Blot, ELISA
Recommended Dilution:
ELISA: 1:1,000
Western Blot: 1:100-500
Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
ZNF319 may be involved in transcriptional regulation.
Applications:
Suitable for use in Western Blot, ELISA
Recommended Dilution:
ELISA: 1:1,000
Western Blot: 1:100-500
Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Shipping & Handling
Shipped In
Cold Packs
Safety & Storage
Storage Temperature
-20°C
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
Specifications
CLASS
Polyclonal Antibodies
SUBCLASS
Transcription Factors, Zinc (Ring) Finger
APPLICATION
E WB
ACCESSION#
NP_065858.1
*USAGE / SAFETY STATEMENT
For laboratory research and development purposes only.
PURITY
Purified by Protein A affinity chromatography.
PHYSICAL FORM
Supplied as a liquid in PBS, pH 7.2, 0.09% sodium azide.
GRADE
Affinity Purified
ANTIBODY TYPE
Pab
HOST SPECIES
human
ISOTYPE
IgG
CROSS REACTIVITY
Hu
IMMUNOGEN
ZNF319 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 505-532 amino acids from the C-terminal region of human ZNF319.
SPECIFIC ACTIVITY
Human
SWISS PROT#
Q9P2F9
COMMODITY CODE
30021010
HOST
rabbit
Questions & Answers (0)
Citations (0)
Shipping & Handling
Shipped In
Cold Packs
Safety & Storage
Storage Temperature
-20°C
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.